Close

Form 3 JOHNSON & JOHNSON For: Jul 02 Filed by: Wengel Kathryn E

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BA
8. SNAP
9. TMUS
10. BIIB


July 11, 2018 7:39 PM EDT
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Wengel Kathryn E
(Last) (First) (Middle)
ONE JOHNSON & JOHNSON PLAZA
(Street)
NEW BRUNSWICK NJ 08933
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/02/2018 		3. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief GSC Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 34,290.0363
D
 
Common Stock 17 (1)
I
By 401k
Common Stock 281 (2)
I
By ESOP
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (Right to Buy) (3) 01/11/2014 01/08/2021 Common Stock 8,238 62.2 D  
Employee Stock Options (Right to Buy) (3) 02/09/2013 02/07/2020 Common Stock 2,017 62.62 D  
Employee Stock Options (Right to Buy) (3) 01/18/2015 01/17/2022 Common Stock 7,877 65.37 D  
Employee Stock Options (Right to Buy) (3) 01/17/2016 01/13/2023 Common Stock 56,410 72.54 D  
Employee Stock Options (Right to Buy) (3) 02/11/2017 02/09/2024 Common Stock 35,638 90.44 D  
Employee Stock Options (Right to Buy) (3) 02/10/2018 02/09/2025 Common Stock 32,762 100.06 D  
Employee Stock Options (Right to Buy) (3) 02/09/2019 02/08/2026 Common Stock 38,945 101.87 D  
Employee Stock Options (Right to Buy) (3) 02/13/2020 02/13/2027 Common Stock 42,965 115.67 D  
Employee Stock Options (Right to Buy) (3) 02/12/2021 02/11/2028 Common Stock 33,044 129.51 D  
Restricted Share Units (4) 02/08/2019   (4) Common Stock 5,882 (4) D  
Restricted Share Units (4) 02/12/2021   (4) Common Stock 1,658 (4) D  
Restricted Share Units (4) 02/13/2020   (4) Common Stock 7,592 (4) D  
Explanation of Responses:
1. Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).
2. Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).
3. Vested and exercisable one day after the third anniversary of the date of the grant.
4. Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.
Remarks:
wengelpoa.txt
Linda E. King, as attorney-in-fact for Kathryn E. Wengel 07/11/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY
Executive Officers

Know all persons by these presents, that the undersigned hereby
constitutes and appoints each of Thomas J. Spellman III, Tina French,
Linda E. King, Maria Frucci and Michelle Ryan, signing singly, as the
undersigned's true and lawful attorneys-in-fact to:

(1)	execute for and on behalf of the undersigned, in the
undersigned's capacity as an executive officer of Johnson & Johnson
(the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934, as amended, and the rules
thereunder (the "Exchange Act") and Form 144 in accordance with Rule
144 of the Securities Act of 1933, as amended (the "Securities Act");

(2)	do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4, 5 and 144 and timely file such form with
the United States Securities and Exchange Commission and any stock
exchange or similar authority; and

(3)	take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in
-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's
substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys
-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the
Exchange Act or Rule 144 of the Securities Act.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file reports pursuant to Section
16 of the Exchange Act with respect to the undersigned's holdings of
and transactions in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of the date set forth below.


		/s/ Kathryn E. Wengel
	Name:  Kathryn E. Wengel
	Date:     July 3, 2018

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings